TAM
IPXL

Tyers Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Tyers Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,128
Closed -$119K – 1017
2018
Q1 		$119K Buy
6,128
+96
+2% +$1.88K ﹤0.01% 815
2017
Q4 		$100K Buy
6,032
+1,328
+28% +$24.3K ﹤0.01% 852
2017
Q3 		$96K Buy
4,704
+368
+8% +$7.04K ﹤0.01% 824
2017
Q2 		$70K Buy
4,336
+1,984
+84% +$29.3K ﹤0.01% 855
2017
Q1 		$30K Buy
2,352
+400
+20% +$4.83K ﹤0.01% 913
2016
Q4 		$26K Buy
+1,952
New +$33.4K ﹤0.01% 891

Tyers Asset Management's IPXL Position: Q2 2018 in Review

Tyers Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 6,128 shares — an estimated $119K sold.

Tyers Asset Management first reported a position in IPXL in Q4 2016 and held it in 6 quarters. The position peaked at $119K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Tyers Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Tyers Asset Management sold 6,128 Impax Laboratories, Inc. shares in Q2 2018, an estimated $119K.
  • Tyers Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 6 quarters.
  • Tyers Asset Management's Impax Laboratories, Inc. position peaked at $119K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Tyers Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.